October 1, 2007: Transcept Pharmaceuticals, Inc. announced that Glenn A. Oclassen, President and Chief Executive Officer, will participate in a panel focused on middle-of-the-night (MOTN) insomnia ( form of insomnia that is characterized by patients who awaken in the middle of the night and have difficulty returning to sleep) at the Natixis Bleichroeder “Hidden Gems” Healthcare Conference... Transcept's Press Release -
Tuesday, October 2, 2007
Transcept Pharmaceuticals, Middle-of-the-Night (MOTN) Insomnia
October 1, 2007: Transcept Pharmaceuticals, Inc. announced that Glenn A. Oclassen, President and Chief Executive Officer, will participate in a panel focused on middle-of-the-night (MOTN) insomnia ( form of insomnia that is characterized by patients who awaken in the middle of the night and have difficulty returning to sleep) at the Natixis Bleichroeder “Hidden Gems” Healthcare Conference... Transcept's Press Release -
